Results 11 to 20 of about 1,378,916 (231)
Urokinase and urokinase receptor in the urinary tract of the dog [PDF]
, 2022 Urokinase (uPA) and urokinase receptor (uPAR) are present in the urinary tract of people, mice, rats and cows. The presence of urokinase and urokinase receptor in the urinary tract of dogs has not been documented. Documenting the presence of uPA and uPAR
Bailey, Trina Racquel +2 more
openaire +2 more sources
Annals of Cardiac Anaesthesia, 2016 Soluble urokinase plasminogen activation receptor (suPAR) is an emerging new biomarker, which has been shown to not only correlate with traditional biomarkers but also outperform CRP at prognosticating CVD.
Nicole B Cyrille +2 more
doaj +2 more sources
The urokinase receptor and the regulation of cell proliferation
Thrombosis and Haemostasis, 2005 SummaryThe urokinase receptor is a multifunctional receptor modulating both proteolytic dependent and independent processes. It binds the extracellular proteolytic enzyme urokinase and engages lateral interactions with several transmembrane receptors, including integrins and the EGFR.
Mazzieri, R, Blasi, F
openaire +6 more sources
The urokinase receptor: a ligand or a receptor? Story of a sociable molecule
Cellular and Molecular Life Sciences, 2006 In this last decade, the structure and functions of the receptor for the urokinase-type plasminogen activator have been extensively studied and characterized. This interesting receptor plays a key role in cell adhesion, migration and proliferation. It was identified 20 years ago as the specific cell-surface molecule that could bind and concentrate ...
RAGNO, Pia, Ragno, P.
openaire +5 more sources
Medical Journal of Babylon, 2023 Background: Type 2 diabetes mellitus is a progressive and chronic disease manifested by β-cell dysfunction and improved insulin resistance. Higher levels of urokinase-type plasminogen activator receptors have been found to predict morbidity and mortality
Melak Saleh Mohammed, Hind Shakir Ahmed
doaj +1 more source
Soluble Urokinase Receptor and Liver Disease. [PDF]
Clin Liver Dis (Hoboken), 2019 Wei C, Zhu K, Zhu K, Reiser J.
europepmc +4 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background Literature suggests a bidirectional association between advanced hepatic fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with immune activation, systemic inflammation, and adverse outcomes in patients with
Vardhmaan Jain +19 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Acute pulmonary embolism (APE) is a debilitating condition with high incidence and mortality rates. APE is widely treated with the serine protease urokinase or urokinase-type plasminogen activator (uPA) that functions by resolving blood clots via ...
Ran Zhu, Ting-Wei Liu, Fan Liu
doaj +1 more source
Hepatology, EarlyView., 2022 KAT7‐acetylated and cytoplasm‐translocated G‐protein GαS enhances IL‐6 effect and drives HCC progenitor cell progression. Abstract Background and Aims Hepatocarcinogenesis goes through HCC progenitor cells (HcPCs) to fully established HCC, and the mechanisms driving the development of HcPCs are still largely unknown.
Ye Zhou +15 more
wiley +1 more source
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung
eLife, 2021 Extensive fibrin deposition in the lungs and altered levels of circulating blood coagulation proteins in COVID-19 patients imply local derangement of pathways that limit fibrin formation and/or promote its clearance.
Alan E Mast +7 more
doaj +1 more source